Darunavir | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Darunavir
Health Canada Patents

AMI Lifesciences is Driven by Chemistry. Powered by People.

Contact Supplier

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

Contact Supplier

Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

Contact Supplier

Quotient Sciences- Molecule to Cure. Fast.

Contact Supplier

pharmacompass-2-m-2025-08-25

Darunavir

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

27 API Suppliers, 20 USDMF, 7 EU WC, 10 NDC API, 11 Listed Suppliers, $ API Reference Price

27 API Suppliers
20 USDMF
7 EU WC
10 NDC API
11 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

68 Drugs in Development

68 Drugs in Development

INTERMEDIATES

24 Intermediate Suppliers

24 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

108 FDF Dossiers, 52 FDA Orange Book, 24 Europe, 4 Canada, 4 Australia, 14 South Africa, 10 Listed Dossiers

108 FDF Dossiers
52 FDA Orange Book
24 Europe
4 Canada
4 Australia
14 South Africa
10 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 150MG, TABLET;ORAL - 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 600MG, TABLET;ORAL - 75MG, TABLET;ORAL - 800MG

TABLET;ORAL - 150MG
TABLET;ORAL - 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 600MG
TABLET;ORAL - 75MG
TABLET;ORAL - 800MG

DIGITAL CONTENT

60 News #PharmaBuzz

60 News #PharmaBuzz

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions, 24 Regulatory FDF Prices, 18 Annual Reports

8 US Medicaid Prescriptions
24 Regulatory FDF Prices
18 Annual Reports

MARKET PLACE

6 APIs, 3 FDF Dossiers

6 APIs
3 FDF Dossiers

PATENTS & EXCLUSIVITIES

28 US Patents, 7 Health Canada Patents

28 US Patents
7 Health Canada Patents

REF. STANDARDS & IMPURITIES

9 Others

9 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 897 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

7 All

01 7Janssen Inc.

filter Patent Reset all filters

7 All

01 12140929

02 12224738

03 12336160

04 22469343

05 22485834

filter Product Reset all filters

7 All

01 7Darunavir

filter Dosage Reset all filters

7 All

01 7Tablet

filter Exp Date Reset all filters

7 All

01 12013-08-24

02 12016-06-28

03 12019-06-23

04 22022-12-12

05 22023-05-16

Product Main Page

01

Janssen Inc.

Darunavir

Coatings Trends

Not Confirmed

Janssen Inc.

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2022-12-12

Date Granted : 2008-05-13

Brand Name : PREZISTA

Patent Number : 2469343

Filing Date : 2002-12-12

Strength per Unit : 300mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2022-12-12

Date Granted : 2008-05-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Janssen Inc.

Darunavir

Coatings Trends

Not Confirmed

Janssen Inc.

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2016-06-28

Date Granted : 2002-08-27

Brand Name : PREZISTA

Patent Number : 2224738

Filing Date : 1996-06-28

Strength per Unit : 300mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-06-28

Date Granted : 2002-08-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Janssen Inc.

Darunavir

Coatings Trends

Not Confirmed

Janssen Inc.

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2013-08-24

Date Granted : 2006-09-12

Brand Name : PREZISTA

Patent Number : 2140929

Filing Date : 1993-08-24

Strength per Unit : 300mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-08-24

Date Granted : 2006-09-12

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Janssen Inc.

Darunavir

Coatings Trends

Not Confirmed

Janssen Inc.

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-05-16

Date Granted : 2007-07-14

Brand Name : PREZISTA

Patent Number : 2485834

Filing Date : 2003-05-15

Strength per Unit : 300mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-05-16

Date Granted : 2007-07-14

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Janssen Inc.

Darunavir

Coatings Trends

Not Confirmed

Janssen Inc.

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-05-16

Date Granted : 2007-07-17

Brand Name : PREZISTA

Patent Number : 2485834

Filing Date : 2003-05-16

Strength per Unit : 400 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-05-16

Date Granted : 2007-07-17

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Janssen Inc.

Darunavir

Coatings Trends

Not Confirmed

Janssen Inc.

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2022-12-12

Date Granted : 2008-05-13

Brand Name : PREZISTA

Patent Number : 2469343

Filing Date : 2002-12-12

Strength per Unit : 400 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2022-12-12

Date Granted : 2008-05-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Janssen Inc.

Darunavir

Coatings Trends

Not Confirmed

Janssen Inc.

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2019-06-23

Date Granted : 2015-02-17

Brand Name : PREZISTA

Patent Number : 2336160

Filing Date : 1999-06-23

Strength per Unit : 400 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2019-06-23

Date Granted : 2015-02-17

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!